biologic

Humatrope

somatropin

Loss of exclusivityFebruary 2011projected — 12-year biologic exclusivity estimate
CompanyEli Lilly and Company

Drug detail

Brand nameHumatrope
Active ingredientsomatropin
Strength6MG
Dosage formFor Injection
RouteSubcutaneous
ModalityBiologic
FDA approvalFebruary 1999
Marketing statusRx

Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the projected — 12-year biologic exclusivity estimate; estimates are projections, not legal advice.

Humatrope patent cliff — loss of exclusivity February 2011 | CliffBio